MICROSCOPY SHARED RESOURCE The Microscopy Shared Resource (MICRO) combines two outstanding microscopy resources, the Microscopy Services Laboratory (MSL) and the Hooker Imaging Core (HIC). The MSL provides confocal imaging, including spectral imaging, spinning disk confocal, standard wide-field imaging on both upright and inverted microscopes and light-sheet microscopy. The HIC provides confocal imaging on both inverted and upright microscopes, wide-field imaging, and high-content imaging for visual drug screens. HIC also houses a multi- photon system for intravital imaging of tissues and organs at cellular scale within a living animal with the option of re-imaging the same animal over time. Dr. James Bear (CCB program co-leader) oversees the SR as faculty director and provides broad scientific direction. Dr. Pablo Ariel, facility director, brings experience in live-cell imaging, image analysis, tissue clearing and light-sheet microscopy. He has 10 years of direct experience in imaging using multiple modalities (widefield, confocal, multiphoton, super resolution, light-sheet) in multiple subject areas. This is a cost-effective service to the members of LCCC. A useful benchmark for comparing microscopy recharge rates is confocal microscopy use, ranges from $16 to $32 per hour, depending on the specific model, at the LCCC MICRO SR. Access to similar equipment at peer institutions ranges from ~$30 to $50 per hour, demonstrating the cost effectiveness of our SR. MICRO SR requests $142,766 for this facility, 21% of the total operating budget. MICRO is a well-established SR with use by 59 LCCC members in eight programs, making up approximately 34% of overall users.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of North Carolina Chapel Hill
Chapel Hill
United States
Zip Code
Waters, Andrew M; Der, Channing J (2018) KRAS: The Critical Driver and Therapeutic Target for Pancreatic Cancer. Cold Spring Harb Perspect Med 8:
Cai, Ling; Tsai, Yi-Hsuan; Wang, Ping et al. (2018) ZFX Mediates Non-canonical Oncogenic Functions of the Androgen Receptor Splice Variant 7 in Castrate-Resistant Prostate Cancer. Mol Cell 72:341-354.e6
Moschos, Stergios J; Sullivan, Ryan J; Hwu, Wen-Jen et al. (2018) Development of MK-8353, an orally administered ERK1/2 inhibitor, in patients with advanced solid tumors. JCI Insight 3:
Brosnan, Evelyn M; Anders, Carey K (2018) Understanding patterns of brain metastasis in breast cancer and designing rational therapeutic strategies. Ann Transl Med 6:163
Valle, Carmina G; Queen, Tara L; Martin, Barbara A et al. (2018) Optimizing Tailored Communications for Health Risk Assessment: A Randomized Factorial Experiment of the Effects of Expectancy Priming, Autonomy Support, and Exemplification. J Med Internet Res 20:e63
Sun, Junjiang; Shao, Wenwei; Chen, Xiaojing et al. (2018) An Observational Study from Long-Term AAV Re-administration in Two Hemophilia Dogs. Mol Ther Methods Clin Dev 10:257-267
Wilczewski, Caralynn M; Hepperla, Austin J; Shimbo, Takashi et al. (2018) CHD4 and the NuRD complex directly control cardiac sarcomere formation. Proc Natl Acad Sci U S A 115:6727-6732
Anderson, Chelsea; Engel, Stephanie M; Anders, Carey K et al. (2018) Live birth outcomes after adolescent and young adult breast cancer. Int J Cancer 142:1994-2002
Gralinski, Lisa E; Sheahan, Timothy P; Morrison, Thomas E et al. (2018) Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis. MBio 9:
Au, Kin Man; Tripathy, Ashutosh; Lin, Carolina Pe-I et al. (2018) Bespoke Pretargeted Nanoradioimmunotherapy for the Treatment of Non-Hodgkin Lymphoma. ACS Nano 12:1544-1563

Showing the most recent 10 out of 1525 publications